COMMUNIQUÉS West-GlobeNewswire

-
GUERBET : Plan stratégique GEAR 2023
18/04/2018 - 07:01 -
DiaMedica Issues Stock Option Grants
18/04/2018 - 03:00 -
ALK’s partner for Japan, Torii, secures pricing for new Japanese cedar SLIT-tablet
18/04/2018 - 03:00 -
Bellicum Pharmaceuticals Announces Pricing of Public Offering of Common Stock
18/04/2018 - 00:26 -
Maple Leaf Begins Constructing the Building Structure on its Telkwa, British Columbia Facility
18/04/2018 - 00:09 -
National Research Corporation Announces Consummation of Class B Common Stock Recapitalization
17/04/2018 - 23:00 -
Encinitas Dentist Urges Screenings in Light of Oral Cancer Awareness Month
17/04/2018 - 23:00 -
Teligent, Inc. Announces FDA Approval of Clobetasol Propionate Cream USP, 0.05%
17/04/2018 - 22:35 -
Marrone Bio Innovations, Inc. Announces Proposed Public Offering of Common Stock
17/04/2018 - 22:30 -
Retrophin to Report First Quarter 2018 Financial Results
17/04/2018 - 22:30 -
EyeGate Announces Completion of $11.25 Million Public Offering
17/04/2018 - 22:30 -
Globus Medical Schedules First Quarter 2018 Earnings Release and Conference Call
17/04/2018 - 22:24 -
Medigus and HC Marbella International Hospital Announce First MUSE™ Procedure for GERD Treatment in Spain
17/04/2018 - 22:05 -
Syneos Health Schedules First Quarter 2018 Earnings Call for Wednesday, May 9, 2018
17/04/2018 - 22:05 -
Intuitive Surgical Announces First Quarter Earnings
17/04/2018 - 22:05 -
GenMark Diagnostics Schedules First Quarter Financial Results Conference Call for May 1, 2018
17/04/2018 - 22:03 -
Novartis presents first-of-its-kind evidence at AAN reinforcing robust and consistent efficacy of AimovigTM* (erenumab) for migraine patients with multiple treatment failures
17/04/2018 - 22:01 -
Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock
17/04/2018 - 22:01 -
Aduro Biotech Highlights Preclinical Data for Three Programs Reported at the American Association for Cancer Research Annual Meeting
17/04/2018 - 22:01
Pages